CD8A and neoplasm: According to one theory, epi-drugs increase the exposure of tumor-associated antigens and upregulate the expression of immune-activating genes in CD8+ T cells, which would synergistically wake up the disabled CD8+ T cells and encourage tumor cleavage in TME [310].